РОЛЬ ЗАБОЛЕВАНИЙ ПАРОДОНТА ПРИ ЗАБОЛЕВАНИЯХ СЕРДЕЧНО‑СОСУДИСТОЙ СИСТЕМЫ
Ключевые слова:
пародонтит, сердечно‑сосудистые заболевания, атеросклероз, системное воспаление, эндотелиальная дисфункция, митральный клапанАннотация
Заболевания пародонта (ЗП), прежде всего хронический генерализованный пародонтит, являются распространёнными воспалительными заболеваниями, затрагивающими до 40–50% взрослого населения. Накопленные данные свидетельствуют о независимой связи ЗП с сердечно‑сосудистыми заболеваниями (ССЗ), включая атеросклеротические события, сердечную недостаточность и нарушение функции эндотелия. Цель настоящего обзора — систематизировать эпидемиологические и механистические доказательства, оценить влияние пародонтальной терапии на кардиоваскулярные биомаркеры.
Библиографические ссылки
Булгакова А.И., Шикова Ю.В., Лиходед А.В. Клинико-иммунобиологическая оценка результатов применения комплекса стоматологических мази и карандаша у больных с воспалительными заболеваниями пародонта // Пародонтология. – 2013. – Т. 17, № 1. – С. 36–39.
Данилов А.С. Половые различия функционального состояния эндотелия сосудов у больных хроническим генерализованным пародонтитом в динамике лечения: дис. … канд. мед. наук. – Саранск, 2015. – 54 с.
Суетенков Д.Е., Акулович А.В., Гриценко Е.А. Качественная и количественная оценка пародонтопатогенной микрофлоры полости рта при помощи BANA-теста // Пародонтология. – 2012. – Т. 17, № 2. – С. 66–70.
Arbildo-Vega H.I., et al. Periodontal disease and cardiovascular disease: umbrella review. PMC, 2024.
Bechina C., et al. Effects of periodontal therapy on cardiovascular risk biomarkers: a systematic review. PMC, 2025.
Bélanger M., Kozarov E., Song H., Whitlock J., Progulske-Fox A. Both the unique and repeat regions of the Porphyromonas gingivalis hemagglutin A are involved in adhesion and invasion of host cells // Anaerobe. – 2012. – Vol. 18(1). – P. 128–134.
Boillot A., Range H., Danchin N., et al. Periodontopathogens antibodies and major adverse events following an acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) // J. Epidemiol. Community Health. – 2016. – Vol. 70. – P. 1236–1241.
Boillot A., Demmer R.T., Mallat Z., et al. Periodontal microbiota and phospholipases: The Oral Infections and Vascular Disease Epidemiology Study (INVEST) // Atherosclerosis. – 2015. – Vol. 242. – P. 418–423.
Braunwald E. Valvular heart diseases. In: Heart Disease. A Textbook of Cardiovascular Medicine. – 6th ed. – Philadelphia: WB Saunders, 2001. – P. 1643–1722.
Brodala N., et al. Porphyromonas gingivalis bacteremia induces coronary and aortic atherosclerosis in normocholesterolemic and hypercholesterolemic pigs // Arterioscler. Thromb. Vasc. Biol. – 2005. – Vol. 25(7). – P. 1446–1451.
Buhlin K., Mäntylä P., Paju S., et al. Periodontitis is associated with angiographically verified coronary artery disease // J. Clin. Periodontol. – 2011. – Vol. 38. – P. 1007–1014.
Camen G.C., Caraivan O., Olteanu M., et al. Inflammatory reaction in chronic periodontopathies in patients with diabetes mellitus: histological and immunohistochemical study // Rom. J. Morphol. Embryol. – 2012. – Vol. 53(1). – P. 55–60.
Chapple I.L., Brock G.R., Milward M.R., Ling N., Matthews J.B. Compromised GCF total antioxidant capacity in periodontitis: cause or effect? // J. Clin. Periodontol. – 2007. – Vol. 34. – P. 103–110.
Chu D., Wang R., Fan Z. Association between cardiovascular diseases and peri-implantitis: a systematic review and meta-analysis // Rev. Cardiovasc. Med. – 2023. – Vol. 24(7). – P. 200.
Damgaard C., Reinholdt J., Enevold C., et al. Immunoglobulin G antibodies against Porphyromonas gingivalis or Aggregatibacter actinomycetemcomitans in cardiovascular disease and periodontitis // J. Oral Microbiol. – 2017. – Vol. 9. – P. 1374154.
European Federation of Periodontology (EFP). Periodontitis: the overlooked cardiovascular risk factor. – 2025. – Доступ: efp.org.
European Federation of Periodontology & World Heart Federation. Perio & Cardio consensus report. – 2020. – Доступ: efp.org; world-heart-federation.org.
GBD 2021. Global, regional, and national burden of periodontal diseases, 1990–2021 // Lancet Oral Health. – 2023.
Gianos E., et al. Oral health and atherosclerotic cardiovascular disease // Curr. Atheroscler. Rep. – 2021.
Herrera D., et al. Association between periodontal disease and coronary heart disease: epidemiology // J. Clin. Periodontol. – 2023. – Vol. 50.
Joseph R., Nath S.G., Joseraj M.G. Elevated plasma homocysteine levels in chronic periodontitis: a hospital-based case-control study // J. Periodontol. – 2011. – Vol. 82(3). – P. 439–444.
Katz J., Chaushu G., Sharabi Y.J. On the association between hypercholesterolemia, cardiovascular disease and severe periodontal disease // Clin. Periodontol. – 2001. – Vol. 28. – P. 865–868.
Li J., et al. Periodontal disease among adolescents and young adults: systematic review // Sci. Rep. – 2025.
Ling M.R., Chapple I.L., Matthews J.B. Neutrophil superoxide release and plasma C-reactive protein levels pre- and post-periodontal therapy // J. Clin. Periodontol. – 2016. – Vol. 43. – P. 652–658.
Lockhart P.B., Bolger A.F., Papapanou P.N., et al. Periodontal disease and atherosclerotic vascular disease: a scientific statement from the American Heart Association // Circulation. – 2012. – Vol. 125(20). – P. 2520–2544.
Molina A., et al. Effect of periodontal therapy on endothelial function and inflammatory markers: review // Frontiers in Oral Health. – 2025.
Nakano K., Nemoto H., Nomura R., et al. Detection of oral bacteria in cardiovascular specimens // Oral Microbiol. Immunol. – 2009. – Vol. 24. – P. 64–68.
Nibali L., D’Aiuto F., Griffiths G., Patel K., Suvan J., Tonetti M.S. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study // J. Clin. Periodontol. – 2007. – Vol. 34. – P. 931–937.
Offenbacher S., Beck J.D., Moss K., et al. Results from the Periodontitis and Vascular Events (PAVE) Study: a pilot randomized controlled trial // J. Periodontol. – 2009. – Vol. 80(2). – P. 190–201.
Padilla C., Lobo O., Hubert G., et al. Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis // J. Periodont. Res. – 2006. – Vol. 41(4). – P. 350–353.
Pattnaik N.K., Das S.N., Biswal B.N. Cardiovascular diseases and periodontal diseases: review and update // Int. J. Sci. Stud. – 2017. – Vol. 5(1). – P. 239–244.
Phelps N.H., Singleton R.K., Zhou B., et al. Worldwide trends in underweight and obesity from 1990 to 2022: pooled analysis of 3663 studies // Lancet. – 2024. – Vol. 403(10431). – P. 1027–1050.
Sanz M., et al. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop // J. Clin. Periodontol. – 2013. – Vol. 40 Suppl 14. – P. S24–S29.
Schenkein H.A., Loos B.G. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases // J. Clin. Periodontol. – 2013. – Vol. 14. – P. 551–569.
Sczepanik F.S.C., Grossi M.L., Casati M., et al. Periodontitis is an inflammatory disease of oxidative stress: we should treat it that way // Periodontol. – 2020. – Vol. 84(1). – P. 45–68.
Su Y., et al. Effect of non-surgical periodontal therapy on coronary artery disease: meta-analysis. – 2025.
Sülc M., Kustrzycki W., Janczak D., et al. Presence of periodontopathic bacteria DNA in atheromatous plaques from coronary and carotid arteries // Biomed. Res. Int. – 2015.
Theofilis T., Sagris M., Oikonomou E., et al. Inflammatory mechanisms contributing to endothelial dysfunction // Biomedicines. – 2021. – Vol. 9(7). – P. 781.
Van Bortel L.M., Laurent S., Boutouyrie P., et al. Expert consensus document on the measurement of aortic stiffness in daily practice // J. Hypertens. – 2012. – Vol. 30(3). – P. 445–448.
Wang X., et al. Age-period-cohort analysis of global periodontal disease trends // BMJ Open. – 2024.
WHO Oral Health Report. Periodontal disease epidemiology and risk factors. – 2023.
Wimmer G., Janda M., Wieselmann-Penkner K., et al. Coping with stress: its influence on periodontal disease // J. Periodontol. – 2002. – Vol. 73(11). – P. 1343–1351.
Xu Y., et al. Global burden of periodontal disease: GBD Study 1990–2021 // BMC Oral Health. – 2024.
Yang J., Wu J., Liu Y., et al. Porphyromonas gingivalis infection reduces regulatory T cells in infected atherosclerosis patients // PLoS One. – 2014. – Vol. 9. – P. 86599.
Haraszthy V.I., Zambon J.J., Trevisan M., Zeid M., Genco R.J. Identification of periodontal pathogens in atheromatous plaques // J. Periodontol. – 2000. – Vol. 71(10). – P. 1554–1560.
Mahendra J., Mahendra L., Kurian V.M., Jaishankar K., Mythilli R. 16S rRNA-based detection of oral pathogens in coronary atherosclerotic plaque // Indian J. Dent. Res. – 2010. – Vol. 21(2). – P. 248–252.
Rizaev JA, Shodmonov AA Optimizing the Surgical Phase of Dental Implants Optimization of the Surgical Phase of Dental Implantation Based on Computer Modeling //Eurasian Medical Research Periodical. – 2022. – T. 12. – S. 84-87.
Rakhimov, N. M., & Shakhanova, S. Sh. (2025). Omega-3 supplementation in combination therapy for anorexia syndrome in metastatic breast cancer. American Journal of Medicine and Medical Sciences.
